Table 2.

Alterations (in fold changes, FC) of proteins relative abundances in groups of the M-series (peripheral blood samples).

The FC are normalized to the control group (G05M, uncomplicated pregnancy, normal outcome) and the data are represented at p < 0.01 unless other is specified in the table’s footnote. Patient with GDM were subdivided according medication strategy: insulin therapy (iGDM) or dietary intervention (dGDM). Apart obesity group (G06), all other studied groups were also stratified according pregnancy outcome in regard of the presence of diabetic fetopathy (DF) or absence (normal course) the signs of DF and other antenatal pathologies observed during pregnancy and in postpartum.

*p < 0.005; **p < 0.001.